Genetic Biomarkers in Chronic Myeloid Leukemia: What Have We Learned So Far?

Chronic Myeloid Leukemia (CML) is a rare malignant proliferative disease of the hematopoietic system, whose molecular hallmark is the Philadelphia chromosome (Ph). The Ph chromosome originates an aberrant fusion gene with abnormal kinase activity, leading to the buildup of reactive oxygen species an...

Descripción completa

Detalles Bibliográficos
Autores principales: Abdulmawjood, Bilal, Costa, Beatriz, Roma-Rodrigues, Catarina, Baptista, Pedro V., Fernandes, Alexandra R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8626020/
https://www.ncbi.nlm.nih.gov/pubmed/34830398
http://dx.doi.org/10.3390/ijms222212516

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8626020/
https://www.ncbi.nlm.nih.gov/pubmed/34830398
http://dx.doi.org/10.3390/ijms222212516

Ejemplares similares